Accenture (ACN) Closes Consultancy Firm LabAnswer Buyout

 | Jul 20, 2017 09:10PM ET

Accenture Plc (NYSE:ACN) recently announced that it has completed the acquisition of LabAnswer, a research and laboratory informatics technology consulting firm. Notably, the two companies had entered into the deal last month. However, financial details of the transaction remain undisclosed.

Headquartered in Sugar Land, TX, LabAnswer is specialized in providing informatics consultancy services to scientific and research laboratories. With approximately 250 employees, apart from life sciences, the company offers its services to various other industries, including chemicals, resources, energy, consumer goods, and government.

With the successful completion of the buyout, the company has established a new business division – Accenture Scientific Informatics Services.

Accenture is planning to leverage its digital technologies such as artificial intelligence, automation, analytics and cloud, with a fundamental redesign of the scientific user experience. With this, the company’s new division will be able to help life sciences companies in better capturing, managing, integrating and analyzing complex research data, thereby giving better ideas to identify new and more effective treatments for patients.

We believe that this acquisition will enhance Accenture’s portfolio of life sciences services. The acquisition of LabAnswer will not only bring in a huge talent pool, but will also expand its reach in different markets.

We are encouraged by Accenture’s strategy of growing through acquisitions. These buyouts have enabled the company to foray into newer markets, diversify and broaden the product portfolio, as well as maintain a leading position. We believe that regular acquisitions will significantly contribute to its revenue stream.

Notably, shares of Accenture have outperformed the Original post

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes